Humana Inc. (NYSE:HUM) Shares Purchased by Principal Financial Group Inc.

Principal Financial Group Inc. lifted its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 2.4% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 170,636 shares of the insurance provider's stock after purchasing an additional 3,961 shares during the quarter. Principal Financial Group Inc. owned about 0.14% of Humana worth $54,047,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Creative Financial Designs Inc. ADV boosted its holdings in Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock valued at $27,000 after acquiring an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. raised its holdings in Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider's stock valued at $28,000 after buying an additional 39 shares during the period. Atwood & Palmer Inc. acquired a new position in Humana during the third quarter valued at approximately $29,000. Your Advocates Ltd. LLP grew its stake in Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock worth $32,000 after buying an additional 45 shares during the period. Finally, Hantz Financial Services Inc. acquired a new stake in shares of Humana in the second quarter worth $35,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Stock Performance

HUM traded down $5.68 during trading on Monday, reaching $282.44. 2,212,620 shares of the company were exchanged, compared to its average volume of 1,873,779. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $527.18. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm has a 50 day moving average of $289.38 and a 200 day moving average of $332.82. The stock has a market cap of $34.01 billion, a P/E ratio of 25.52, a PEG ratio of 2.28 and a beta of 0.52.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts' consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion for the quarter, compared to analysts' expectations of $28.66 billion. On average, sell-side analysts forecast that Humana Inc. will post 15.83 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.25%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana's dividend payout ratio is presently 31.36%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on HUM. Truist Financial decreased their price target on shares of Humana from $400.00 to $260.00 and set a "hold" rating for the company in a research report on Friday, October 11th. TD Cowen upped their target price on Humana from $261.00 to $268.00 and gave the stock a "hold" rating in a research report on Monday, November 4th. UBS Group dropped their target price on Humana from $380.00 to $250.00 and set a "neutral" rating on the stock in a report on Friday, October 4th. Barclays boosted their price target on Humana from $250.00 to $253.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 31st. Finally, Jefferies Financial Group downgraded shares of Humana from a "buy" rating to a "hold" rating and lowered their price objective for the company from $519.00 to $253.00 in a research report on Monday, October 7th. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, Humana currently has a consensus rating of "Hold" and a consensus price target of $315.86.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.